ClearNote Health
Empowering early cancer detection
San Diego, United States · Founded 2016 · $193.8M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- clearnotehealth.com
- Total Funding
- $193.8M
- Last Round
- $52.0M Series DMay 2026
- Rounds
- 4
About
ClearNote Health develops blood-based early cancer detection tests and epigenomics software using cell-free DNA methylation. Its Avantect tests target high-mortality cancers with limited detection options, including pancreatic and ovarian cancer. The company's Virtuoso epigenomics platform supports biopharma drug discovery.
Summary
ClearNote Health is a Healthcare company based in San Diego, United States, founded in 2016. It has raised $193.8M in total across 4 rounds, most recently a $52.0M Series D round in May 2026. Investors include Mattias Westman and Unknown.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.